2018/02/19 January 30, 2018 – Takara Bio’s Board of Directors resolved today to establish a new facility for the research and manufacturing of regenerative medical products in coordination with the expansion of existing research and manufacturing facilities at the company’s head office site in Kusatsu, Shiga. Total project cost is expected to be around 7.3... Read more
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) announced today that a federal jury in San Francisco has ruled in its favor in a patent infringement suit filed against Ariosa Diagnostics, Inc., now owned by Roche. The jury found that both Ariosa’s previous and current version of the Harmony non-invasive prenatal test (NIPT) infringe US Patent 8,318,430... Read more
New product expands treatment options for bovine respiratory disease (BRD) in cattle OAKWOOD VILLAGE, Ohio, Jan. 24, 2018 /PRNewswire/ — The antimicrobial gamithromycin is now available on microbroth dilution susceptibility plates, giving veterinary microbiology laboratories the means to perform susceptibility testing on organisms that cause bovine respiratory disease (BRD) in beef and non-lactating dairy cattle, and expanding... Read more
The SCIEX Citrine™ MS/MS medical device provides clinical labs with one solution to tackle today’s difficult assays, and the versatility to address tomorrow’s precision medicine and wellness testing January 23, 2018 Framingham, MA — SCIEX Diganostics, the in vitro diagnostics division of SCIEX, a global leader in mass spectrometry in the life sciences industry, announced today the launch... Read more
HERCULES, Calif. — January 22, 2018 — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the IH-Incubator L and IH-Centrifuge L instruments to be used with the full range of Bio-Rad’s IH-System... Read more
2018 2018/01/19 First patient enrolled into phase I/II clinical trial of NY-ESO-1・siTCR gene therapy against synovial sarcoma in Japan Kusatsu/Shiga, Japan — January 17, 2018 — Takara Bio Inc. (Takara Bio), today announced that the first patient with synovial sarcoma has been enrolled into NY-ESO-1・siTCR gene therapy (TBI-1301) phase I/II clinical trial in Japan on January... Read more
Gyrolab Generic TK Kit for early-stage biotherapeutic development, optimized for use in Gyrolab systems Uppsala, Sweden, 16 January 2018: Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, announced today it has introduced a new reagent kit for early-stage biotherapeutic toxicokinetic (TK) studies. The... Read more
As President, Dawn Barry will be responsible for leading operations, communicating and implementing company mission, and guiding overall strategy, direction, and growth at Luna DNA. SAN DIEGO, Jan. 15, 2018 /PRNewswire/ — Luna DNA, the first and only genomic and medical research knowledge base powered by the blockchain and owned by its community, announced today Dawn Barry as president. In... Read more
The latest version of Sapientia™, v1.7, is to be released today (15th January 2018) bringing with it an array of infrastructure improvements, alongside three key new features: a simple and practical ACMG Guidelines interface, improved gene panel management and the first look at the automated interpretation request template. Version 1.7 is underpinned by a significant... Read more
Thermo Fisher Scientific Designs Flexible Manufacturing Site for Flexion Therapeutics, Inc. DURHAM, N.C., Jan. 11, 2018 /PRNewswire/ — Thermo Fisher Scientific Inc., the world leader in serving science, announced today that manufacturing of Zilretta™, is underway at its Swindon, U.K. site where a custom “condo” manufacturing suite has been installed to support the launch of Flexion’s... Read more